Using Data For Decision Making

Similar documents
HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

Until recently, countries in Eastern

TB/HIV in the WHO European Region Overview, Priorities & Response

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

EASTERN EUROPE AND CENTRAL ASIA

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

HIV Prevention Prioritization & Implementation Brief: Anambra State

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

HIV Prevention Prioritization & Implementation Brief: Kaduna State

HIV and Hepatitis Prevention Programmes in Eastern Europe Case Example: Georgia

who inject drugs THE GAP REPORT 2014

UNGASS COUNTRY PROGRESS REPORT Republic of Armenia

HIV Prevention Prioritization & Implementation Brief: Gombe State

May 26-28, 2010, Almaty, Kazakhstan November 2011

Key issues for HIV testing and

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

HIV Prevention Prioritization & Implementation Brief: Lagos State

HIV Prevention Prioritization & Implementation Brief: Benue State

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

Combating HIV/AIDS and TB in Eastern Europe and Central Asia: The World Bank Response

Population. B.3. HIV and AIDS. There has been mixed progress in reducing new HIV infections and AIDSrelated

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

Vol. 5, No. 20 Fall 2010

SDG 2: Target 3.7: Indicators Definitions, Metadata, Trends, Differentials, and Challenges

Workbook Method for estimating HIV prevalence in low level or concentrated epidemics

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy

Vol. 6, No. 21 Winter

HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy

HIV/AIDS and Human Rights: Conflicts and Synergies

FACT SHEET TAJIKISTAN (REPUBLIC OF)

Implementing a priority national health care project in Russian Federation (HIV prevention and treatment)

Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

HIV AND PEOPLE WHO INJECT DRUGS

Vol. 6, No. 23 Summer 2011

Module 1: HIV epidemiology, transmission and prevention

THE BENCHMARK. UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response.

Epidemiological trends of TB in Eastern Europe TB and migration

Knowledge, Attitudes and Behavior Related to HIV/AIDS among Transport Sector Workers

Eastern Europe and Central Asia

Ending the AIDS epidemic by 2030

HIV in Russia: the situation in vulnerable groups and NGO opportunities in response to the epidemic

aids in asia and the pacific

HIV and AIDS in Asia and the Pacific: A review of progress towards Universal Access

Measuring TB burden and access to TB services for people who inject drugs in the WHO European Region, 2010 and 2011

Detection of Hepatitis B and C in Primary Care

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

S P. HIV/AIDS Resource Allocation and the Goals Model. Steven Forsythe, PhD Futures Institute/INSP

Main global and regional trends

FACT SHEET 1 IRAN (ISLAMIC REPUBLIC OF)

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

Vol. 5, No. 18 Spring 2010

THE REPUBLIC OF BELARUS

Civil Society Driven Response in Ukraine: A program making a difference and bringing results

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)

Summary Report - IBBS Balochistan - Quetta Round 1, ROUND 1 SUMMARY REPORT -BALOCHISTAN QUETTA

Towards universal access

Key words: YIDUs, condom use behaviour

The cancer burden in the European Union and the European Region: the current situation and a way forward

Report of the 16 th. Core Group meeting Almaty, Kazakhstan May 26-28, 2010

Integration of collaborative TB/HIV activities with harm reduction services

National Transition Strategy to Replace CFC-based. MDIs with in the Commonwealth of Independent States. Paul Krajnik UNIDO, Montreal Protocol Branch

MDR-TB and HIV co-infection in Eastern Europe. Francis Drobniewski MBBS PhD Professor of Global Health and Tuberculosis

An Assessment of the HIV/AIDS Epidemic in Central Asia. and. the Central Asia AIDS Control Project

Name of the presenter

GAVI in the WHO European Region: results, current status and future

Strategic use of antiretroviral drugs to prevent HIV transmission

HIV/AIDS INDICATORS. AIDS Indicator Survey 8 Basic Documentation Introduction to the AIS

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

United Nations Office on Drugs and Crime (UNODC)

Strategic Planning for HIV/AIDS

Young People and HIV/AIDS

Patterns of Marriage, Sexual Debut, Premarital Sex, and Unprotected Sex in Central Asia. Annie Dude University of Chicago

Tuberculosis surveillance in Germany. Data of the tuberculosis report 2013

Poliomyelitis eradication in the WHO European Region

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Getting to zero HIV new infections in Asia and the Pacific region: Possible or impossible dream?

Program to control HIV/AIDS

China Country Advocacy Brief Injecting Drug Use and HIV

Figure 1: Estimated number of people living with HIV, Percentage of population in urban areas

Supporting the Establishment of Prison- based Harm Reduction Policies and Programs in Eastern Europe and the Former Soviet Union

CHAIR: DR JORGE SAMPAIO, UN SECRETARY-GENERAL'S SPECIAL ENVOY TO STOP TB AND FORMER PRESIDENT OF THE PORTUGUESE REPUBLIC

European Action Plan for HIV/AIDS

Injecting Drug Use and the Harm Reduction Model_Merritt_HPP-507. This paper explores the role that law enforcement and police actions can play as

Progress in Flour Fortification in Central and Eastern Europe and Commonwealth of Independent States

Government of Canada Federal AIDS Initiative Milestones

Hepatitis C in the WHO European Region

Asia is large and diverse. HIV/AIDS: Regional and Thailand. The Asian HIV Epidemic. Praphan Phanuphak, M.D., Ph.D.

Ministry of Health of the Republic of Belarus Joint United Nations Programme on HIV/AIDS (UNAIDS) BELARUS

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Cover Image: Creative Commons Doctor s Office by Lily A. is licensed under CC BY-NC-ND 2.0.

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

Highlighting in the WHO European Region:

HIV and Harm Reduction in Prisons

HIV/AIDS: Transport workers take action. International Transport Workers Federation (ITF)

HIV/AIDS and young people Training course in sexual and reproductive health research Geneva 2010

The Global Fund s view on transition Dumitru Laticevschi The Global Fund

Access update, registration & procurement strategies Christophe PERRIN Pharmacist, TB supply - MSF

HIV prevalence and risk behaviors amongst men who have sex with. men in Hong Kong: a systematic review. (Ref. No.: R05-12)

Transcription:

Using Data For Decision Making Juliana Víctor-Ahuchogu World Bank

Acknowledgment and data sources AIDS in the Commonwealth of Independent States: AIDS 2008 MAP Report: Magomed Nashkhoev & Boris Sergeyev, accessible at: www.unaids.ru Andrew Wilson, Liza Shurik, Anja Nitzsche- Bell & Igor Toskin MAP 2008 Report primary data collection teams: Azerbaijan, Tajikistan, Belarus, Georgia, Turkmenistan, Kazakhstan, Ukraine, Kyrgyzstan, Moldova, Uzbekistan 2

Critical Questions in Decision- Making Are we doing the right thing? Are we doing it right? Are we doing enough of it? 3

What have we always known about the HIV epidemic in the region? Injecting drug use remains the driving force behind the HIV epidemic in the region 4

RESPONDING TO CONCENTRATED IDU EPIDEMICS Throughout Asia and Eastern Europe, IDU drives HIV, directly and by injecting HIV into commercial sex networks Injecting drug use the spark plug that ignites sexual transmission, sex work the engine that maintains it European and Asian data shows how injecting drug use fuels HIV in sex work, fundamentally amplifying epidemic potential Eastern Europe, Central Asia, Iran, Afghanistan, Pakistan, Indonesia, Philippines lands of opportunity - effective IDU programs can radically curtail sexual epidemics 5

RESPONDING TO CONCENTRATED IDU EPIDEMICS Yet real world experience discouraging Can we keep saying that harm reduction works, for example, in former Soviet Union or Asia, when we can t convince authorities it is preferable to coercion? Limited progress towards large-scale harm reduction programs in Asia, with partial exception of substitution therapy in China Yet, if we can increase programs, we have inherent advantages - unlike condoms, which inhibit spontaneity, no-one WANTS to share dirty needles 6

HIV Prevalence among IDUs in Nine CIS states 2003 2006 (2006 UNGASS Reports) 25 23.2 20 15 10 12.4 5 10.9 5 6.2 9.2 13 5 1 0 Russia Ukraine Belarus Moldova Kazakhstan Kyrgyzstan Armenia Georgia Azerbaijan

Coverage of prevention services among IDUs still low in most countries In most CIS countries, police are known to arrest IDUs for possession of even minimal amount of narcotics. As a result of the fear of incarceration or of being registered as a drug user, many IDUs do not seek treatment or even clean needles!!! How can we match evidence and programmatic decision-making? 8

Percentage of IDUs reached by prevention programs, 2005 source: 2006 UNGASS Reports 70 69.3 63.3 60 50 % 40 30 25.1 25 30 22.3 28.9 20 16.4 10 0 4.9 Arm Geo Rus Ukr Bel Kyr Taj Mol Arm 9

Behavior change still a challenge among IDUs High levels of needle- and syringe sharing: Russia: 30-40%, Tajikistan: 55%, Kyrgyzstan: 70% (prisons Patterns of adopting protective behaviors differ significantly throughout the region: Moldova: 60%, 20% or less in Georgia, Ukraine and Kyrgyzstan Even higher levels of sharing injecting paraphernalia (containers, filters) and water to prepare drug solution 10

IDU Equipment-Sharing Practices Source: MAP Report, 2007 % of IDUs 60 50 40 30 20 10 Sharing Needles Sharing instruments 0 Tajikistan Kazakhstan Kyrgyzstan Ukraine Moldova 11

Sexual Behavior of IDUs Drug users are sexually active - 86% St. Petersburg > 80% Ekaterinburg Multiple sex partnerships common Concurrent sex partnerships common Armenia, 63% more than one partner in last 12 months 54% two or more partners concurrently 12

Female sex workers Sex industry experienced a dramatic growth after the collapse of the Soviet Union Most are between 20 and 25 years of age, however a significant proportion of sex workers are under the age of 18 Many women travel outside the region for sex work and outside their country within the region. 13

HIV prevalence among female sex workers Ukraine: prevalence varied for 4% in Kiev to 24% in Donetsk and 27% in Mikolayev Russia: prevalence ranged from 15% in Moscow to 48% in St Petersburg and 62% in Togliatti. High overlap between sex work and injecting drug use communities in most of the region. 14

HIV Prevalence among sex workers in eight CIS countries Source: 2006 UNGASS Reports Armenia 0,4% Georgia 1,2% Kyrgyzstan 0,1% Kazakhstan 2,5% Moldova 8,4% Russia 3,1% Tajikistan 0,7% Ukraine 8,0% 0,0% 1,0% 2,0% 3,0% 4,0% 5,0% 6,0% 7,0% 8,0% 9,0% 15

Condom Use during commercial sex is high. Source CDC, (HIV SS, 2005, Kazakhstan, Kyrgyzstan, Uzbekistan) 100% 91% 90% 87% 80% 72% 70% 61% 60% 50% 40% 30% 20% 10% 48% 83% 0% Kazakhstan (N=1960) Kyrgyzstan (N=349) Uzbekistan (N=315) Have condoms at the moment of interview Used condoms during the last commercial sexual intercourse

CIS epidemics remain focused in specific populations & their partners Clients Low or no risk males FSW Low or no risk females IDUs Limited generalized spread Focused prevention effective Intensified efforts among bridging populations needed Adapted responses needed as epidemic changes (adapted from Brown & Walker 2005)

But coverage (prevention) among female sex workers is low. 80.0% 75.7% 75.3% 70.0% 60.0% 62.3% 50.0% 40.0% 30.0% 28.9% 34.0% 20.0% 10.0% 8.8% 14.1% 16.0% 0.0% Armenia Belorussia Georgia Kyrgyzstan Moldova Russia Tajikistan Ukraine (2006 UNGASS Reports, NAC data) 18

Injecting drug users selling sex Russia: 15%-50% of female IDU sell sex and 30% of sex workers inject drugs Injecting sex workers more frequently nonsterile injecting equipment Female injectors more likely to share needles or syringes than male injectors 19

Shooting up: Epidemics in IDU are injecting HIV into heterosexual groups The Main Routes of HIV Transmission in Russia, 2001-2006 % 100 80 60 40 20 0 2001 2002 2003 2004 2005 2006 Injecting drug use Heterosexual sex (Data source Russia, Ukraine, Belarus : MAP Report 2007) 20

Distribution of HIV infection by Transmission Routes, Ukraine:2001-2005 # of newly reported cases 7000 6000 5000 4000 3000 2000 1000 0 6270 5778 4587 4815 4586 3964 4041 3043 2499 1885 2001 2002 2003 2004 2005 IDUs Heterosexual Transmission HIV infection by Transmission Routes, Belarus: 2001-2005 100% 50% 0% 2001 2002 2003 2004 2005 Heterosexual Transmission IDU Mother to Child Transmission Diagnosed in MSM

Case Study, Using Data to improve Resource allocation, Russia In 2004: Low spending: Only 0.2% of the total Russian health budget was allocated to HIV/AIDS treatment and prevention in 2004. Imbalance in spending for prevention activities: close to 50% spent on blood safety, one-fifth of the funds aimed at mother-to-child transmission and 30% was spent on mass media activities (almost zero spending on MARPs). 22

NASA Study Results, Russian Federation, 2004 Allocations by functions, source UNAIDS Russia 23

Allocation to Prevention Activities, Russian Federation, 2004, source UNAIDS Russia 24

Russia: Improvements in funding allocation Based on the findings of the NASA study, in 2006-2007, the Russian government increased funding for HIV/AIDS In 2006 the government allocated 18 times more funding than in 2005 In 2007, the federal budget allocations for HIV/AIDS was three times higher than in 2006 In 2006, 20.30% of the total allocation for HIV/AIDS was used for prevention (source, Russian Federation UNGASS Report, Jan 2006- Dec 2007) 25

MSM Remains the least-researched of the most-at-risk groups in CIS Available data on prevalence and risk behaviours is limited Most data collected from venues such as gay nightclubs young adults <30 No data from Azerbaijan, Tajikistan, Turkmenistan, the Ukraine and Uzbekistan Russia, 4.8% in Ekaterinburg and 14.3% in Volgograd; Georgia: 3.2%; Moldova: 2.5% 26

Migration, mobility and HIV Significant role in the epidemic? HIV prevalence data missing Data on risk behaviour patterns missing Caucasian Republics: Azerbaijan data suggests 45% of HIV positive population infected abroad Central Asia: Tajikistan reports >50% of HIV cases are among seasonal workers 27

Discussion: Significant challenges What can we learn from Ukraine, Kyrgyzstan and Tajikistan and other countries which report no barriers for IDUs in accessing preventive services? Because despite strong anti-narcotics policies and punitive measures towards IDUs, most of the countries in the CIS have experienced a significant increase in injecting drug use in the last decade. 28

Significant challenges: 2 Govt size estimate reports and other sources do not match, leading to mismatch in resource allocation Sometimes up to 50% of VCT clients do not return for their results. How can we resolve this situation? Geographic targeting within countries, are we doing the right thing? 29

Why is there a mismatch between evidence and response? What are the critical challenges How can these challenges be overcome? 30